Osteoporosis drugs and jaw problems. Weighing your risks
Mayo Clinic Health Letter 24(12): 6
2006
ISSN/ISBN: 0741-6245 PMID: 17304694 Document Number: 602310
Document emailed within 1 workday
Related Documents
Ro, K.G.; Anderson, H.V. 1990: Thrombolytic therapy in acute MI. Weighing the risks and benefits Postgraduate Medicine 88(8): 79-80 83-6 89-90 PassimRane, A.; Söderman, P.; Wallin, A. 1985: Drugs and breast feeding: risks for the child exposed to drugs via breast milk Lakartidningen 82(45): 3919-3924
Nargeolet, H. 1972: Misuse of drugs and excess of self-administered drugs. Administrative and legislative problems Therapie 27(2): 289-295
Jacob, J.; Barthelemy, C. 1972: Misuse of drugs and excess of self-administered drugs. Problems posed for the pharmacologist Therapie 27(2): 189-217
Holland, M.G. 1974: Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs Annals of Ophthalmology 6(5): 447-450 Passim
Evreux, J.C.; Lery, N.; Vigneau, C.; Roche, L.; Faucon, G. 1972: Misuse of drugs and excess of self-administered drugs. Problems posed for the toxicologist. II. Survey on drug use Therapie 27(2): 273-287
Liew, Y.L.; Mann, D.; Piterman, L. 2002: Osteoporosis risks. a comparative study of Asian Australian and Caucasian Australian women Australian Family Physician 31(3): 291-293; 297
Halse, J.; Falch, J.; Haug, E.; Jorde, R.; Nesheim, B.I.; Nordal, K.P.; Skjaeraasen, J.; Aanderud, S. 1995: Osteoporosis drugs prescribed on blue forms! Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 115(24): 3050-3051
Taga, M. 2002: Drugs in development for the treatment of osteoporosis:Raloxifene Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 572-580
Gorai, I. 2002: Drugs in development for the treatment of osteoporosis: Tibolone Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 3): 552-571
Sahu, S. 1981: Risks of drugs to the fetus and the neonate American Family Physician 24(4): 147-149
Vokrouhlická, O.; Horn, V.; Silinková-Málková, E.; Pacovský, V. 1978: On the problems of spinal column "osteoporosis" Casopis Lekaru Ceskych 117(38-39): 1190-1193
Heidelmann, G. 1979: Problems of high-dose sodium fluoride therapy in osteoporosis. 3. Practice of osteoporosis therapy with sodium fluoride Zeitschrift für Arztliche Fortbildung 73(12): 581-584
Reginster, J.Y. 1996: Prevention of postmenopausal osteoporosis: estrogens and nonhormonal drugs Revue Medicale de Liege 51(10): 649-653
Ammann, P.; Rizzoli, R.; Bonjour, J.P. 1999: Animal models for the preclinical testing of drugs against osteoporosis Revue du Rhumatisme 66(11): 532-533
Kern, S.I. 2010: Controlled drugs: how to minimize the risks to you and your patients Medical Economics 87(15): 50-51
Kraupp, O. 1976: Risks of long-term administration of drugs Wiener Klinische Wochenschrift 88(2): 45-51
Veronika, C.; Aron, F.; Peter, S. 2016: Safety risks of over-the-counter (OTC) drugs and their management Acta Pharmaceutica Hungarica 86(4): 151-159
Andriani, A. 1976: Problems and risks of the legalization of abortion Minerva Ginecologica 28(9): 736-737
Hesch, R.D.; Galanski, M.; Prokop, M.; Rittinghaus, E.F. 1988: Current problems in osteoporosis from the clinical and radiologic viewpoints Der Radiologe 28(4): 143-148